VITROS SARS-CoV-2 IgG Controls Kit (VITROS Anti SARS-CoV-2 IgG Controls) for Immunodiagnostic Determination of IgG Antibodies to SARS-CoV-2 Using Enhanced Chemiluminescence on VITROS Series Analyzers, Lot 0120

VITROS SARS-CoV-2 IgG Controls Kit (VITROS Anti SARS-CoV-2 IgG Controls) for Immunodiagnostic Determination of IgG Antibodies to SARS-CoV-2 Using Enhanced Chemiluminescence on VITROS Series Analyzers, Lot 0120

The kit is intended for the immunodiagnostic determination of class G immunoglobulins (IgG) to the SARS-CoV-2 coronavirus using enhanced chemiluminescence on VITROS series analyzers.

Contents:

• Control 1 (Negative Control) – 3 vials, 2.0 mL each
• Control 2 (Positive Control) – 3 vials, 2.0 mL each

Lot: 0120

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, VITROS SARS-CoV-2 IgG Controls Kit (VITROS Anti SARS-CoV-2 IgG Controls) for Immunodiagnostic Determination of IgG Antibodies to SARS-CoV-2 Using Enhanced Chemiluminescence on VITROS Series Analyzers, Lot 0120, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.